tiprankstipranks
Trending News
More News >
Jacobson Pharma Corporation Limited (HK:2633)
:2633
Hong Kong Market
Advertisement

Jacobson Pharma Corporation Limited (2633) Stock Statistics & Valuation Metrics

Compare
3 Followers

Total Valuation

Jacobson Pharma Corporation Limited has a market cap or net worth of HK$3.17B. The enterprise value is HK$3.63B.
Market CapHK$3.17B
Enterprise ValueHK$3.63B

Share Statistics

Jacobson Pharma Corporation Limited has 2,000,221,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,000,221,000
Owned by Insiders
Owned by Institutions

Financial Efficiency

Jacobson Pharma Corporation Limited’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 9.96%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)9.96%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee911.50K
Profits Per Employee215.97K
Employee Count1,730
Asset Turnover0.43
Inventory Turnover2.66

Valuation Ratios

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio11.0
PS Ratio0.00
PB Ratio1.37
Price to Fair Value0.96
Price to FCF7.84
Price to Operating Cash Flow6.77
PEG Ratio0.72

Income Statement

In the last 12 months, Jacobson Pharma Corporation Limited had revenue of 1.58B and earned 300.83M in profits. Earnings per share was 0.15.
Revenue1.58B
Gross Profit692.94M
Operating Income414.60M
Pretax Income373.63M
Net Income300.83M
EBITDA558.87M
Earnings Per Share (EPS)0.15

Cash Flow

In the last 12 months, operating cash flow was 495.44M and capital expenditures -65.47M, giving a free cash flow of 429.97M billion.
Operating Cash Flow495.44M
Free Cash Flow429.97M
Free Cash Flow per Share0.21

Dividends & Yields

Jacobson Pharma Corporation Limited pays an annual dividend of HK$0.115, resulting in a dividend yield of 3.89%
Dividend Per ShareHK$0.115
Dividend Yield3.89%
Payout Ratio23.03%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.21
52-Week Price Change203.70%
50-Day Moving Average1.55
200-Day Moving Average1.15
Relative Strength Index (RSI)49.94
Average Volume (3m)1.11M

Important Dates

Jacobson Pharma Corporation Limited upcoming earnings date is Nov 21, 2025, TBA (Confirmed).
Last Earnings DateJun 13, 2025
Next Earnings DateNov 21, 2025
Ex-Dividend DateAug 11, 2025

Financial Position

Jacobson Pharma Corporation Limited as a current ratio of 1.88, with Debt / Equity ratio of 31.52%
Current Ratio1.88
Quick Ratio1.27
Debt to Market Cap0.30
Net Debt to EBITDA0.47
Interest Coverage Ratio10.02

Taxes

In the past 12 months, Jacobson Pharma Corporation Limited has paid 72.79M in taxes.
Income Tax72.79M
Effective Tax Rate0.19

Enterprise Valuation

Jacobson Pharma Corporation Limited EV to EBITDA ratio is 4.67, with an EV/FCF ratio of 9.37.
EV to Sales1.65
EV to EBITDA4.67
EV to Free Cash Flow9.37
EV to Operating Cash Flow4.95

Balance Sheet

Jacobson Pharma Corporation Limited has HK$563.79M in cash and marketable securities with HK$699.85M in debt, giving a net cash position of HK$136.06M billion.
Cash & Marketable SecuritiesHK$563.79M
Total DebtHK$699.85M
Net CashHK$136.06M
Net Cash Per ShareHK$0.07
Tangible Book Value Per ShareHK$1.04

Margins

Gross margin is 43.94%, with operating margin of 26.29%, and net profit margin of 19.08%.
Gross Margin43.94%
Operating Margin26.29%
Pretax Margin23.69%
Net Profit Margin19.08%
EBITDA Margin35.44%
EBIT Margin26.32%

Analyst Forecast

The average price target for Jacobson Pharma Corporation Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast7.43%
EPS Growth Forecast21.88%

Scores

Smart Score8
AI Score74.4
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis